Aethlon Medical, Inc.

Aethlon Medical (NASDAQ: AEMD) is focused on addressing unmet needs in global health and biodefense. The Aethlon Hemopurifier® is a first-in-class therapeutic device designed to address life-threatening viral infections. The United States Food and Drug Administration (FDA) has designated the Hemopurifier® to an Expedited Access Pathway (EAP) related to the treatment of life-threatening…More viruses that are not addressed with approved therapies.